# Dose-Escalation Study of Carboplatin Administration Into the Brain for Glioblastoma Multiforme

> **NCT01317212** · PHASE1 · WITHDRAWN · sponsor: **North Bristol NHS Trust**

## Conditions studied

- Glioblastoma Multiforme

## Interventions

- **DRUG:** Peritumoural carboplatin administration.

## Key facts

- **NCT ID:** NCT01317212
- **Lead sponsor:** North Bristol NHS Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-05
- **Primary completion:** 2017-05
- **Final completion:** 2018-05
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Sufficient funding could not be secured for the study
- **Last updated:** 2015-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01317212

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01317212, "Dose-Escalation Study of Carboplatin Administration Into the Brain for Glioblastoma Multiforme". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01317212. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*